Funding for this research was provided by:
Received: 22 March 2018
Accepted: 17 October 2018
First Online: 13 November 2018
Ethics approval and consent to participate
: The study was approved by Muhimbili University of Health and Allied Sciences Research Ethical Review Board as well as the WHO Ethics Review Committee. Before the fieldwork, permission to conduct the study was obtained from the District Executive Director for Rufiji. Members of the community were informed of the purpose of the study during the village meetings in order to obtain their cooperation. Before any examination, a written informed consent was obtained from all adults. For children below 15 years, their parents/guardians signed the informed the consent on their behalf. Before setting the CDC light and gravid traps, written informed consent was obtained from the heads of the households and individuals sleeping in the mosquito collection rooms were provided with long-lasting insecticide-treated nets (LLINs). Study participants who were positive for CFA or MF were treated with ivermectin (150–200 mg/kg) and albendazole (400 mg) as done during MDA.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.